✦ LIBER ✦

511 Paclitaxel ± ifosfamide in advanced ovarian cancer (A.O.C.). Preliminary results of a multicentric pilot study

✍ Scribed by L. Miglietta; D. Amoroso; M. Bruzzone; C. Granetto; E. Catsafados; S. Mammoliti; D. Guarneri; F. Pedullà; G. Foglia; N. Ragni; F. Boccardo

Book ID: 116167264
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 162 KB
Volume: 31
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(95)95765-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

492 Safety and efficacy of taxol® (pacli

492 Safety and efficacy of taxol® (paclitaxel) over 3 h in 306 platinum-refractory patients with ovarian cancer: Results of a German cooperative study

✍ U. Klaassen; K. Kühndel; T. Bauknecht; H. Kühnle; C. Fackisch; W. Jonat; R. Schu 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 139 KB

49 Adjuvant high dose chemotherapy (H.D.

49 Adjuvant high dose chemotherapy (H.D. CT) without bone marrow rescue in breast cancer patients (B.C. Pts) with 10 or more positive axillary nodes (N ≥ 10): Preliminary findings from a grocta pilot study

✍ F. Brema; F. Patrone; D. Amoroso; A. Ballestrero; C. De Sanctis; F. Ferrando; U. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 164 KB

PA.122 COMBINATION CHEMOTHERAPY (CT) WIT

PA.122 COMBINATION CHEMOTHERAPY (CT) WITH DOCETAXEL (D), OXALIPLATIN (O), CAPECITABINE (C) IN PATIENTS (PTS) WITH ADVANCED GASTRIC CANCER (AGC): PRELIMINARY RESULTS ON TOXICITY OF A PILOT STUDY

✍ A. Buonadonna; R. Cannizzaro; A.M. Colussi; S. Rosalen; E. Turchet; G. Tabaro; S 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 65 KB

372 Neo-adjuvant chemotherapy in locally

372 Neo-adjuvant chemotherapy in locally advanced beast cancer (LABC): FEC (5FU, epirubicin, cyclophosphamide) vs high dose intensity EC + G-CSF (Filgrastim). An EORTC—NCIC—SAKK study. Preliminary results of dose intensity (DI)

✍ P. Therasse; C. Tsitsa; T. Sahmoud; E. Tomiak; A. Goldhirsch; M. Piccart 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 154 KB

511 Paclitaxel&#xa0;±&#xa0;ifosfamide in advanced ovarian cancer (A.O.C.). Preliminary results of a multicentric pilot study

511 Paclitaxel ± ifosfamide in advanced ovarian cancer (A.O.C.). Preliminary results of a multicentric pilot study